The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia
Open Access
- 1 November 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 107 (3) , 660-664
- https://doi.org/10.1111/j.1476-5381.1992.tb14503.x
Abstract
The hyperalgesic activities in rats of interleukin‐1β (IL‐1β), IL‐6, IL‐8, tumour necrosis factor α (TNFα) and carrageenin were investigated. IL‐6 activated the previously delineated IL‐1/prostaglandin hyperalgesic pathway but not the IL‐8/sympathetic mediated hyperalgesic pathway. TNFα and carrageenin activated both pathways. Antiserum neutralizing endogenous TNFα abolished the response to carrageenin whereas antisera neutralizing endogenous IL‐1β, IL‐6 and IL‐8 each partially inhibited the response. The combination of antisera neutralizing endogenous IL‐1β + IL‐8 or IL‐6 + IL‐8 abolished the response to carrageenin. These results show that TNFα has an early and crucial role in the development of inflammatory hyperaglesia. The delineation of the roles of TNFα, IL‐1β, IL‐6 and IL‐8 in the development of inflammatory hyperalgesia taken together with the finding that the production of these cytokines is inhibited by steroidal anti‐inflammatory drugs provides a mechanism of action for these drugs in the treatment of inflammatory hyperalgesia.Keywords
This publication has 30 references indexed in Scilit:
- Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.Journal of Clinical Investigation, 1991
- Cytokine Inhibition by A Novel Steroid, Mometasone FuroateImmunopharmacology and Immunotoxicology, 1991
- Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration “in vivo” by indirect mechanismsInflammation Research, 1990
- Endothelial Cell Gene Expression of a Neutrophil Chemotactic Factor by TNF-α, LPS, and IL-1βScience, 1989
- Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogueNature, 1988
- Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1987
- A peripheral sympathetic component in inflammatory hyperalgesiaEuropean Journal of Pharmacology, 1987
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoidsNature, 1980
- INTRAVENOUS REGIONAL SYMPATHETIC BLOCK WITH GUANETHIDINEThe Lancet, 1974